Skip to main content
Premium Trial:

Request an Annual Quote

Louis Drapeau

Bio-Rad has appointed Louis Drapeau to the company’s board of directors.
Drapeau will also serve on the board’s audit committee.
He is currently CFO of Nektar Therapeutics, a drug-development firm that recently named former Sirna Therapeutics head Howard Robin as its president and CEO.
Previously, Drapeau held various executive positions at BioMarin Pharmaceutical. He holds a BS in mechanical engineering and an MBA from Stanford University.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.